Clinical Trials Logo

Clinical Trial Summary

This study will test the efficacy and safety of AIN457 for patients with active uveitis that requires systemic immunosuppression.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Active Uveitis That is Not From an Infection.
  • Uveitis

NCT number NCT00685399
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 2
Start date June 2008
Completion date September 2013